Unlike other viral or bacterial coinfections that negatively impact respiratory viral diseases such as COVID-19, some parasitic infections could modulate disease severity and the clinical outcome of other infectious diseases such as COVID-19 via intricate molecular networks involving HLA-G, IL-10/TGF-β, and Treg cells [103,118,120]. This evidence concerns the gene TGFB1 and COVID-19.